from the sequencing-for-fun-and-profit dept.
corded writes "Yesterday, deCODE genetics announced the launch of their $985 personal genotyping product, deCODEme (video), beating their competitors to market. Perhaps not coincidentally, 23andMe's website is suddenly much more informative today, and the New York Times features a preview of 23andMe's $999 offering. deCODEme and 23andMe will scan about a million and 600,000 sites across the genome, respectively and assess your risk for common diseases, along with providing information about ancestry, physical traits, and the ability to compare genes with friends and family."
You can do this in a number of ways. IBM chose to do all of them.
Why do you find that funny?
-- D. Taylor, Computer Science 350